RMG Wealth Management
VRTX icon

RMG Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

RMG Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.81K Hold
9
– – ﹤0.01% 357
2026
Q2 		$4.73K Sell
9
-10
-53% -$4.43K ﹤0.01% 361
2026
Q1 		$8.27K Buy
19
+10
+111% +$4.66K ﹤0.01% 308
2025
Q4 		$4.21K Buy
+9
New +$3.88K ﹤0.01% 315

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

RMG Wealth Management's VRTX Position: Q3 2026 in Review

RMG Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 9 shares worth $4.81K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

RMG Wealth Management first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.27K in Q1 2026. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • RMG Wealth Management held 9 shares of Vertex Pharmaceuticals worth $4.81K as of Q3 2026.
  • RMG Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #357 holding.
  • RMG Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • RMG Wealth Management's Vertex Pharmaceuticals position peaked at $8.27K in Q1 2026.
  • 1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.